Innovatus Capital Partners
20
68M
16
2.50
4
0.20
8
- Areas of investment
Summary
The main department of described VC is located in the New York. The fund was located in North America if to be more exact in United States.
The overall number of key employees were 8.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Innovatus Capital Partners, startups are often financed by CRG L.P., Windham Venture Partners, Tullis Health Investors. The meaningful sponsors for the fund in investment in the same round are WuXi NextCODE, Telegraph Hill Partners, TPG Biotech.
The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Innovatus Capital Partners works on 21 percentage points more the average amount of lead investments. Speaking about the real fund results, this VC is 55 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2019. The fund is generally included in less than 2 deals every year.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline DNAnexus, Personal Genome Diagnostics (PGD) The fund has no exact preference in some founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Biotechnology, Bioinformatics. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund.
Investments analytics
Analytics
- Total investments
- 20
- Lead investments
- 4
- Exits
- 8
- Rounds per year
- 2.50
- Follow on index
- 0.20
- Investments by industry
- Biotechnology (14)
- Health Care (13)
- Medical (11)
- Genetics (7)
- Health Diagnostics (7) Show 17 more
- Investments by region
-
- United States (18)
- Germany (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 25M
- Group Appearance index
- 0.50
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
JenaValve Technology | 31 Aug 2022 | Health Care, Medical Device, Medical | Late Stage Venture | 100M | Munich, Bavaria, Germany |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.